Ipidacrine (Axamon), A Reversible Cholinesterase Inhibitor, Improves Erectile Function in Male Rats With Diabetes Mellitus-Induced Erectile Dysfunction

ABSTRACTS: Background: Management of diabetes mellitus-induced erectile dysfunction (DMED) is challenging because of its insufficient responses to phosphodiesterase type 5 inhibitors. Aim: To compare the effects of ipidacrine, a reversible cholinesterase inhibitor, and sildenafil on DMED in a rat m...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Vladimir Bykov, MD, PhD, Evgenia Gushchina, Sergey Morozov, PhD, Natalia Zhuravskaya, Kirill Kryshen, PhD, Valery Makarov, MD, PhD, Aleksandr Matichin, Alena Zueva
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Oxford University Press 2022-02-01
coleção:	Sexual Medicine
Assuntos:	Erectile Dysfunction Ipidacrine Maximum Intracavernous Pressure
Acesso em linha:	http://www.sciencedirect.com/science/article/pii/S2050116121001574
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!